RICHMOND, Calif., Jan. 4, 2018 /PRNewswire/
-- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today
that Dr. Sandy Macrae, CEO of
Sangamo, will present at the 36th Annual J.P. Morgan
Healthcare Conference on Wednesday, January
10th at 4:00 p.m.
PT. Dr. Macrae's presentation will be followed by a separate
Q&A session starting at 4:30 p.m.
PT. The conference is being held in San Francisco, CA from January 8-11, 2018.
The presentation and Q&A session will be webcast live and
may be accessed via a link on the Sangamo Therapeutics website in
the Investors and Media section under Events and
Presentations. The presentation will be archived on the Sangamo
website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc.
is focused on translating ground-breaking science into genomic
therapies that transform patients' lives using the company's
industry leading platform technologies in genome editing, gene
therapy, gene regulation and cell therapy. For more information
about Sangamo, visit www.sangamo.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300577746.html
SOURCE Sangamo Therapeutics, Inc.